Report

PROMOPHARM : Un coup de froid au S1 2017

  • Des ventes moins importantes au marché public au terme du S1 2017 ;
  • Un BFR en dégradation induisant un endettement net entièrement court terme ;
  • Un résultat net en recul de 25,3% à M MAD 34.
Underlying
Promopharm

Provider
BMCE Capital Global Research
BMCE Capital Global Research

BMCE Capital Global Research is a subsidiary of BMCE Capital Group dedicated to Research and Financial Analysis. It is addressed to professional investors (financial institutions, management companies, etc.) to which it provides information and independent analysis aligned with international standards. BMCE Capital Research covers equities, interest rate, Forex and commodities markets in Morocco, Tunisia and WAEMU region (Bourse Régionale des Valeurs Mobilières, BRVM). Thanks to its latest generation technology platform, to its teams and to those of its partners, the Research Office of BMCE Capital is now able to cover simultaneously several places in Africa and to produce several publications co-branded under its umbrella brand African Securities Network, ASN.

Other Reports on these Companies
Other Reports from BMCE Capital Global Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch